LITHIUM CAPSULE #1

1. INDICATIONS AND USE

LITHIUM capsule No. 1 is indicated for:

OBSTETRICS/GYNECOLOGY

Adjunctive therapy for pain during sexual intercourse in women with:

• vaginismus
• vaginal infections
• problem with the cervix
• problems with the uterus, including fibroids
• endometriosis
• problems with ovaries
• pelvic inflammatory diseases
• ectopic pregnancy
• menopause
• after surgery or childbirth
• sexually transmitted diseases
• trauma to the vulva or vagina, including a tear during childbirth or a cut (episiotomy)
• vulvodynia

2. EXECUTION TIME

2.1 Recommended

In the morning

During the daytime

2.2 Not recommended

In the evening

At night

3. FREQUENCY OF USE

3.1 Use in patients aged 18 years and over 

The minimum course of therapy is 4 weeks. It is recommended:

• 1 time per day
• as needed

3.2 Use in the elderly

No adjustment of the frequency of administration is required in these patients.

3.3 Administrative information

You can perform the practice sitting or lying down in any comfortable position.

4. EFFECTIVENESS AND THERAPEUTIC EFFECT

4.1 Start of action

From 2 days

4.2 Maximum effect

From 2 weeks

 

4.3 Decrease in action

From 5 weeks

4.4 Therapeutic effect 

From 2 weeks

5. CONTRAINDICATIONS

5.1 Not recommended for use in patients

There are no contraindications

6. WARNINGS AND PRECAUTIONS

6.1 Impact on driving vehicles

Does not affect the ability to drive a car

6.2 Drowsiness/sedation

No drowsiness or sedation observed.

7. INTERACTIONS WITH OTHER PRACTICES AND DRUGS

There are no contraindications

Can level out (reduce):

Negative effects of poor quality meditation practices on brain function

Harmful effects of taking medications and drugs

8. USE IN SPECIFIC GROUPS

8.1 Pregnancy

No adjustment of frequency of use is required during pregnancy.

8.2 Lactation period

No adjustment of the frequency of administration is required during lactation.

8.3 Use in pediatrics

Not recommended for persons under 18 years of age

8.4 Geriatric use

No adjustment of the frequency of administration is required in individuals over 65 years of age.